Chronic lymphocytic leukemia and Priapism: An Unusual association

Priapism is a prolonged penile erection, unrelated to sexual arousal. It can lead to permanent tissue damage if not promptly managed. While it is more commonly associated with hematologic disorders such as sickle cell disease and hypercoagulable states, priapism in chronic lymphocytic leukemia (CLL) is exceptionally rare. There are few published case reports regarding CLL presenting with priapism as initial manifestation of the disease. This is a case of a 67-year-old male with CLL on monitoring, presented to the ED with priapism and further evaluation revealed a WBC count of 186.9 k correlating to his CLL diagnosis. The priapism was initially thought to be secondary to trazodone and was subsequently discontinued. The patient presented again in 2 weeks with priapism despite discontinuing trazodone with an elevated WBC count of 246.6 k, uptrending WBC count. The priapism was considered to be secondary to CLL, further imaging revealed extensive lymphadenopathy in the chest and upper abdomen (largest lymph node 2.7 cm). He was started on Obinutuzumab and responded well with a decrease in WBC count to 6.65 k after just one dose of Obinutuzumab. The priapism was resolved successfully without recurrence. The patient is currently being treated with Obinutuzumab and Venetoclax. Priapism can be a sign of progression as seen in the above case or as an initial manifestation of CLL. It happens due to leukostasis, where high leukocyte counts cause blood stasis in the penile vasculature. Hyperviscosity and leukemic cell infiltration of penile tissue may further contribute to blood flow obstruction, leading to priapism. This case emphasizes the need to consider hematologic malignancies, such as CLL, as potential causes of priapism in patients with high WBC counts. Immediate intervention is essential to prevent permanent penile damage. • Priapism secondary to CLL is a rare association • Diagnosis and management of CLL in time plays a key role in preventing complications • Priapism can be an initial presentation or manifestation of progression in CLL patients • Leukemias should be considered in patients with priapism with abnormal cell counts.

Authors

Institutions

Publication Details

Journal
Medical Reports
Published
2025-06-24
DOI
https://doi.org/10.1016/j.hmedic.2025.100295
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chronic lymphocytic leukemia and Priapism: An Unusual association

Devin Malik, Jahnavi Ethakota, Palak Grover, Bipneet Singh et al.
Medical Reports
Chronic Lymphocytic Leukemia Research
article

Chronic lymphocytic leukemia and Priapism: An Unusual association

Devin Malik, Jahnavi Ethakota, Palak Grover, Bipneet Singh, Sakshi Bai, Danesh Kumar
article en

Abstract

Priapism is a prolonged penile erection, unrelated to sexual arousal. It can lead to permanent tissue damage if not promptly managed. While it is more commonly associated with hematologic disorders such as sickle cell disease and hypercoagulable states, priapism in chronic lymphocytic leukemia (CLL) is exceptionally rare. There are few published case reports regarding CLL presenting with priapism as initial manifestation of the disease. This is a case of a 67-year-old male with CLL on monitoring, presented to the ED with priapism and further evaluation revealed a WBC count of 186.9 k correlating to his CLL diagnosis. The priapism was initially thought to be secondary to trazodone and was subsequently discontinued. The patient presented again in 2 weeks with priapism despite discontinuing trazodone with an elevated WBC count of 246.6 k, uptrending WBC count. The priapism was considered to be secondary to CLL, further imaging revealed extensive lymphadenopathy in the chest and upper abdomen (largest lymph node 2.7 cm). He was started on Obinutuzumab and responded well with a decrease in WBC count to 6.65 k after just one dose of Obinutuzumab. The priapism was resolved successfully without recurrence. The patient is currently being treated with Obinutuzumab and Venetoclax. Priapism can be a sign of progression as seen in the above case or as an initial manifestation of CLL. It happens due to leukostasis, where high leukocyte counts cause blood stasis in the penile vasculature. Hyperviscosity and leukemic cell infiltration of penile tissue may further contribute to blood flow obstruction, leading to priapism. This case emphasizes the need to consider hematologic malignancies, such as CLL, as potential causes of priapism in patients with high WBC counts. Immediate intervention is essential to prevent permanent penile damage. • Priapism secondary to CLL is a rare association • Diagnosis and management of CLL in time plays a key role in preventing complications • Priapism can be an initial presentation or manifestation of progression in CLL patients • Leukemias should be considered in patients with priapism with abnormal cell counts.

Medical ReportsVol. 13
Henry Ford Hospital (US)
Good health and well-being
Openalex Percentile: Top 79%
Chronic Lymphocytic Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.